gsk201205036k3.htm
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending May 2012
 
GlaxoSmithKline plc
(Name of registrant)


 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.


 
 
Yes      No x
--
 
 
 
 

 
 

 

 
 
GlaxoSmithKline plc - Result of AGM
 
 
GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting (AGM) today, all resolutions were passed by shareholders.
 
GlaxoSmithKline AGM Poll Results
 
The following table shows the votes cast for each resolution:
 
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
Adoption of Directors' Report and Financial Statements
3,827,705,365
98.70
50,361,254
1.30
3,878,066,619
3,315,549
2
Approval of the Remuneration Report
3,641,744,377
95.70
163,812,052
4.30
3,805,556,429
75,828,261
3
Re-election of Sir Christopher Gent
3,757,599,321
96.90
120,406,731
3.10
3,878,006,052
3,377,349
4
Re-election of Sir Andrew Witty
3,874,304,280
99.90
3,878,779
0.10
3,878,183,059
3,214,858
5
Re-election of Professor Sir Roy Anderson
3,874,110,361
99.90
3,788,474
0.10
3,877,898,835
3,482,154
6
Re-election of Dr Stephanie Burns
3,874,188,220
99.90
3,706,042
0.10
3,877,894,262
3,485,110
7
Re-election of Stacey Cartwright
3,871,534,437
99.84
6,292,248
0.16
3,877,826,685
3,552,308
8
Re-election of Larry Culp
3,863,938,369
99.65
13,752,888
0.35
3,877,691,257
3,689,401
9
Re-election of Sir Crispin Davis
3,872,742,523
99.87
5,082,798
0.13
3,877,825,321
3,554,050
10
Re-election of Simon Dingemans
3,873,781,085
99.90
3,931,792
0.10
3,877,712,877
3,666,495
11
Re-election of Judy Lewent
3,871,977,307
99.85
5,954,264
0.15
3,877,931,571
3,447,684
12
Re-election of Sir Deryck Maughan
3,865,657,282
99.69
12,144,052
0.31
3,877,801,334
3,578,315
13
Re-election of Dr Daniel Podolsky
3,867,010,327
99.72
10,760,012
0.28
3,877,770,339
3,608,654
14
Re-election of Dr Moncef Slaoui
3,873,750,729
99.89
4,223,699
0.11
3,877,974,428
3,406,260
15
Re-election of Tom de Swaan
3,798,800,827
97.96
78,991,586
2.04
3,877,792,413
3,586,579
16
Re-election of Sir Robert Wilson
3,873,643,265
99.89
4,247,312
0.11
3,877,890,577
3,489,128
17
Re-appointment of auditors
3,796,598,526
99.27
27,986,430
0.73
3,824,584,956
56,794,117
18
Remuneration of auditors
3,843,027,589
99.46
20,772,856
0.54
3,863,800,445
17,579,487
19
Authority for the company to make donations to political organisations and incur political expenditure
3,806,217,378
98.23
68,562,707
1.77
3,874,780,085
6,605,082
20
Authority to allot shares
3,773,307,135
97.35
102,769,873
2.65
3,876,077,008
5,304,590
21
Disapplication of pre-emption rights***
3,833,012,357
98.94
40,945,524
1.06
3,873,957,881
7,422,017
22
Authority for the company to purchase its own shares***
3,860,354,462
99.55
17,589,398
0.45
3,877,943,860
3,443,301
23
Exemption from statement of senior statutory auditor's name
3,852,410,960
99.51
18,979,169
0.49
3,871,390,129
9,991,468
24
Authorise reduced notice of a general meeting other than an AGM***
3,521,062,642
90.83
355,321,668
9.17
3,876,384,310
4,998,426
25
Renew the GSK ShareSave Plan
3,791,116,168
97.83
83,969,018
2.17
3,875,085,186
6,344,467
26
Renew the GSK ShareReward Plan
3,832,667,502
98.91
42,189,238
1.09
3,874,856,740
6,574,197
 
Notes:
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority.
 
James Murdoch did not stand for re-election as a Director, and has stepped down from the Board with effect from noon today.
 
The following table provides further relevant information:
 
 
GlaxoSmithKline's
Twelfth AGM
(2012)
GlaxoSmithKline's
Eleventh AGM
(2011)
Issued share capital
(excluding Treasury Shares)
5,046,404,827
5,163,907,153
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
76.91%
74.72%
Total shareholder population
147,408
155,990
Total number of proxies lodged
9,717
9,886
% of shareholders who lodged proxies
6.59%
6.34%
Number of shareholders, corporate representatives and proxies who attended the AGM
426
364
 
V A Whyte
Company Secretary
3 May 2012
 
These results will shortly be available on the company's website at www.gsk.com.
 
GlaxoSmithKline Enquiries:
      
UK Media enquiries:
David Mawdsley
+44 (0) 20 8047 5502
(London)
 
Stephen Rea
+44 (0) 20 8047 5502
(London)
 
Sarah Spencer
+44 (0) 20 8047 5502
(London)
 
David Daley
+44 (0) 20 8047 5502
(London)
       
US Media enquiries:
Kevin Colgan
+1 919 483 2839
(North Carolina)
 
Melinda Stubbee
+1 919 483 2839
(North Carolina)
 
Sarah Alspach
+1 919 483 2839
(Washington, DC)
 
Jennifer Armstrong
+1 919 483 2839
(Philadelphia)
       
Analyst/Investor enquiries:
Sally Ferguson
+44 (0) 20 8047 5543
(London)
 
Tom Curry
+ 1 215 751 5419
(Philadelphia)
 
Gary Davies
+ 44 (0) 20 8047 5503
(London)
 
Jeff McLaughlin
+ 1 215 751 7002
(Philadelphia)
 
Ziba Shamsi
+ 44 (0) 20 8047 3289
(London)
       
     
   
   
   
   
                 
 

 






 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.



 
 
GlaxoSmithKline plc
(Registrant)


Date: May 03, 2012 
 
 
By: VICTORIA WHYTE
------------------
 
 
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc